News Formal

HHS recommendation to reschedule cannabis keeps pot stocks hot, but questions remain

  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 34 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 17%
  • Publisher: 97%

Россия Новости Новости

Россия Последние новости,Россия Последние новости

The DEA is not bound to follow the U.S. Health and Human Services Department's recommendation to reclassify marijuana as a Schedule III drug.

The move by the Drug Enforcement Administration to review the Schedule I classification for cannabis sparked a wave of speculation and mostly positive comments from Wall Street on Thursday, but many questions remain.

Cresco Labs CRLBF, +11.29% was rallying by 9.4%, Green Thumb Industries GTBIF, +16.22% was up by 10.5% and Trulieve Cannabis TCNNF, +21.41% was up by 13.7%. During a Senate hearing in March, Garland reiterated a statement he made at his confirmation hearing that the Justice Department’s position on cannabis will be “very close to what was done” in the Cole memorandum, which was a policy put in place in 2013 that limited the role of federal law-enforcement regarding cannabis.

It’s also widely agreed that the Food and Drug Administration would be poised to regulate cannabis, but uncertainties remain over what that would look like, Zuanic said.

 

Спасибо за ваш комментарий. Ваш комментарий будет опубликован после проверки
Мы обобщили эту новость, чтобы вы могли ее быстро прочитать.Если новость вам интересна, вы можете прочитать полный текст здесь Прочитайте больше:

 /  🏆 3. in RU

Россия Последние новости, Россия Последние новости

Similar News:Вы также можете прочитать подобные новости, которые мы собрали из других источников новостей

Pot stocks rally after health officials ask DEA to reclassify marijuana as lower-risk drugAssistant Secretary for Health Rachel Levine reportedly requested in a letter to DEA Administrator Anne Milgram that marijuana be downgraded to a schedule III substance.
Источник: FoxBusiness - 🏆 458. / 53 Прочитайте больше »